PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,541 | -46.7% | 13,526 | -44.3% | 0.00% | – |
| Q2 2023 | $440,026 | -33.3% | 24,284 | -2.1% | 0.00% | – |
| Q1 2023 | $659,494 | +33.8% | 24,793 | -2.8% | 0.00% | – |
| Q4 2022 | $492,818 | +317.6% | 25,495 | +351.1% | 0.00% | – |
| Q3 2022 | $118,000 | +1211.1% | 5,652 | +382.7% | 0.00% | – |
| Q2 2022 | $9,000 | -35.7% | 1,171 | -43.2% | 0.00% | – |
| Q1 2022 | $14,000 | -86.7% | 2,062 | -73.5% | 0.00% | – |
| Q4 2021 | $105,000 | +26.5% | 7,785 | +58.0% | 0.00% | – |
| Q3 2021 | $83,000 | -32.5% | 4,927 | +16.8% | 0.00% | – |
| Q2 2021 | $123,000 | +1.7% | 4,219 | +37.2% | 0.00% | – |
| Q1 2021 | $121,000 | +51.2% | 3,076 | -12.2% | 0.00% | – |
| Q4 2020 | $80,000 | +627.3% | 3,505 | +601.0% | 0.00% | – |
| Q3 2020 | $11,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |